Twelve-month resistance and impact exercise program or risedronate provides a relative benefit to hip bone structure in postmenopausal women: results from a randomized controlled trial

R. Blay,L.E. Flores,K. Kupzyk,N. Waltman,J. Lappe,L. Mack,L. Bilek
DOI: https://doi.org/10.1007/s00198-023-07008-x
2024-02-19
Osteoporosis International
Abstract:Bone strength estimates are important for fracture prevention. This study compared bone strength changes in postmenopausal women with low bone mass who were assigned to 12 months of exercise, a bone medication, or control. Exercise and bone medications benefited structure at the hip. Structure should be considered in fracture prevention research.
endocrinology & metabolism
What problem does this paper attempt to address?